Virtual Incision’s appointment of Jim Alecxih as Chief Executive Officer marks a strategic step forward in accelerating the company’s mission to transform robotic-assisted surgery. Alecxih brings over three decades of experience in the medical device industry, notably from his leadership at Intuitive Surgical, where he played a pivotal role in the commercial success of the da Vinci Surgical System. His background aligns seamlessly with Virtual Incision’s vision of reshaping minimally invasive surgery through its flagship platform, the MIRA Surgical System, and the upcoming M2 miniaturized robotic system.

The MIRA and M2 platforms represent a new era in surgical robotics by offering smart, simple, and small solutions that eliminate the cost and complexity of traditional cart-based systems. With their compact footprint and single-port design, these systems are engineered to provide advanced surgical capabilities in settings previously underserved by robotics—such as rural hospitals, ambulatory surgical centers (ASCs), and hospital outpatient departmVeteran MedTech Executive to Lead Commercialization of MIRA and M2 Platforms, Expanding Access to Robotic-Assisted Surgery Globallyents (HOPDs). This expansion of access is particularly important in democratizing robotic-assisted surgery for a broader population of patients and providers.

With Alecxih’s leadership, Virtual Incision is poised to scale commercialization, pursue FDA submissions in multiple specialties, and solidify its role as a disruptor in surgical technology. As the company gains momentum with recent innovation accolades, including recognition from Fast Company and Fierce MedTech, the focus now shifts to global adoption and clinical impact. Alecxih’s appointment reinforces the company’s commitment to making robotic surgery more accessible, flexible, and scalable—ultimately improving surgical outcomes and expanding the reach of life-changing technology.